Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
+ND Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
+ND Capital

+ND Capital

Operating

California-based ND Capital is a venture capital firm investing in disruptive technologies since 2002.

Location
San Mateo, CA, US
Founded
2002
Firm
Compare
Portfolio
Employees
Website

Investments

Partillion Bioscience
Partillion Bioscience

Total Raised

$6.1M

Rounds

5

Seed$5MSeptember 2023
Airna
Airna

Total Raised

$30M

Rounds

1

Series A$30MSeptember 2023
Natron Energy
Natron Energy
Series Unknown

Total Raised

$304.2M

Rounds

10

Series D$35MJuly 2020
Orca Bio
Orca Bio

Total Raised

$192M

Rounds

3

Series D$192MJune 2020
SQZ Biotechnologies
SQZ Biotechnologies
Public

Total Raised

$229.8M

Rounds

14

Series D$65MMay 2020
Series C$72MAugust 2018
Series B$16MSeptember 2016
Amphivena Therapeutics
Amphivena Therapeutics

Total Raised

$135.7M

Rounds

5

Series C$62MSeptember 2019
Inscripta
Inscripta

Total Raised

$463.9M

Rounds

9

Series C$20MApril 2019
Series C$30MDecember 2018
Series C$55.5MFebruary 2018
Series B$23MFebruary 2017
Serotiny
Serotiny

Total Raised

$3.1M

Rounds

2

Seed$3MJuly 2018
Emulate
Emulate

Total Raised

$224.3M

Rounds

9

Series B$17MOctober 2016
Series A$12MJuly 2014
Twist Bioscience
Twist Bioscience
Public

Total Raised

$553.1M

Rounds

11

Series D$61MJanuary 2016
Series C$37MJune 2015
Series B$26MMay 2014
Selecta Biosciences
Selecta Biosciences
Public

Total Raised

$380.5M

Rounds

21

Series E$38MSeptember 2015
Private Equity$20MOctober 2014
Series C$15MApril 2010
View
View
Public

Total Raised

$2.6B

Rounds

21

Series Unknown$12.6MNovember 2013
Series D$55MJune 2012
Series C$40MDecember 2010
SBA Materials
SBA Materials

Total Raised

$29.6M

Rounds

10

Series Unknown$5.2MJanuary 2010